Notice
28 Aug 2025
regulatory compliance, fda, drug development, public workshop, patient experience data
💊FDA Workshop on Patient Experience Data and Drug Development
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Patient-Focused Drug Development: Workshop #2 to Discuss Methodologic and Other Challenges Related to Patient Experience Data." The purpose of the public workshop is to discuss methodological challenges related to patient experience data, and other areas of greatest interest or concern to public stakeholders.
Learn More